← Back to Search

EQUITY GI for Colorectal Cancer

N/A

Waitlist Available

Led By Sakti Chakrabarti, MD

Research Sponsored by Case Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Newly diagnosed Black GI cancer participants irrespective of stage. Eligible tumor types include anal carcinoma, rectal cancer, colon cancer, small bowel cancer, appendix carcinoma, hepatobiliary cancer, pancreatic cancer, gastroesophageal cancer, gastrointestinal neuroendocrine tumors, and gastrointestinal stromal tumor

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 months

Awards & highlights

Study Summary

This trial aims to improve the care of individuals with gastrointestinal cancer. It has three main parts: ensuring proper biomarker testing and evidence-based care, helping participants enroll in clinical trials, and increasing health literacy

Who is the study for?

This trial is for Black adults aged 18 or older who have been newly diagnosed with various types of gastrointestinal cancers, including those affecting the colon, rectum, stomach, pancreas, liver and more. Participants must be able to follow study procedures and give informed consent.Check my eligibility

What is being tested?

EQUITY GI aims to improve care quality by ensuring proper biomarker testing for personalized treatment plans and assisting with clinical trial enrollment. It also focuses on enhancing health literacy through educational materials about participants' conditions.See study design

What are the potential side effects?

Since this study involves standard-of-care treatments rather than experimental drugs, side effects will vary based on individual treatments received. These could range from digestive issues to fatigue or skin reactions depending on the specific therapies.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am Black and have a newly diagnosed GI cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Biomarker testing rate of Black participants diagnosed with GI cancer

Secondary outcome measures

Change in Health literacy score among black participants diagnosed with GI cancer

Change in Health literacy test among black participants diagnosed with GI cancer

Clinical trial enrollment rate among black participants diagnosed with GI cancer

Trial Design

1Treatment groups

Experimental Treatment

Group I: EQUITY GIExperimental Treatment1 Intervention

Data gathering Program development and implementation Health literacy

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor

452 Previous Clinical Trials

31,710 Total Patients Enrolled

Sakti Chakrabarti, MDPrincipal InvestigatorUniversity Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

1 Previous Clinical Trials

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently seeking participants for this clinical trial?

"According to clinicaltrials.gov, recruitment for this study is currently closed. The trial was initially listed on July 1st, 2024 and last updated on February 8th, 2024. Despite the pause in enrollment for this particular trial, there are over two thousand other trials open for patient participation at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

2024. "EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06263088.

All > Anal Cancer > Neuroendocrine Tumor